Middle aortic syndrome
ORPHA:1456Acute myeloid leukemia and myelodysplastic syndromes related to alkylating agent
ORPHA:102379Acute myeloid leukemia and myelodysplastic syndromes related to radiation
ORPHA:164726Acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor
ORPHA:102381Alpha-thalassemia-myelodysplastic syndrome
ORPHA:231401CNTNAP2-related developmental and epileptic encephalopathy
ORPHA:163681Dentin dysplasia-sclerotic bones syndrome
ORPHA:99792Ectodermal dysplasia syndrome
ORPHA:79373Familial atypical multiple mole melanoma syndrome
ORPHA:404560Ghosal hematodiaphyseal dysplasia
ORPHA:1802Isotretinoin-like syndrome
ORPHA:2306Microcephaly-capillary malformation syndrome
ORPHA:294016Microphthalmia with linear skin defects syndrome
ORPHA:2556Myelodysplastic neoplasm with increased blasts
ORPHA:86839Myelodysplastic neoplasm with increased blasts type 1
ORPHA:100019Myelodysplastic neoplasm with increased blasts type 2
ORPHA:100020Myelodysplastic neoplasm with low blasts
ORPHA:98826Myelodysplastic syndrome
ORPHA:52688Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality
ORPHA:86841Myelodysplastic/myeloproliferative disease
ORPHA:98275Senior-Loken syndrome
ORPHA:3156Spondylodysplastic Ehlers-Danlos syndrome
ORPHA:536471Therapy related acute myeloid leukemia and myelodysplastic syndrome
ORPHA:86846Unclassified myelodysplastic syndrome
ORPHA:98827Unclassified myelodysplastic/myeloproliferative disease
ORPHA:98825